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Abstract
Several protocols have been developed for human induced pluripotent stem cell neuronal differentiation. We compare
several methods for forebrain cortical neuronal differentiation by assessing cell morphology, immunostaining and gene
expression. We evaluate embryoid aggregate vs. monolayer with dual SMAD inhibition differentiation protocols, manual vs.
AggreWell aggregate formation, plating substrates, neural progenitor cell (NPC) isolation methods, NPC maintenance and
expansion, and astrocyte co-culture. The embryoid aggregate protocol, using a Matrigel substrate, consistently generates a
high yield and purity of neurons. NPC isolation by manual selection, enzymatic rosette selection, or FACS all are efficient, but
exhibit some differences in resulting cell populations. Expansion of NPCs as neural aggregates yields higher cell purity than
expansion in a monolayer. Finally, co-culture of iPSC-derived neurons with astrocytes increases neuronal maturity by day 40.
This study directly compares commonly employed methods for neuronal differentiation of iPSCs, and can be used as a
resource for choosing between various differentiation protocols.
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Introduction
Since the advent of human induced pluripotent stem cell
(hiPSC) technology, numerous studies have utilized these cells for
neuronal differentiation. Several groups have independently
developed hiPSC neuronal differentiation protocols, often adapted
from existing protocols for human embryonic stem cells (ESCs) or
mouse iPSCs/ESCs [1–10]. These protocols are constantly being
improved and revised, creating a plethora of techniques to
differentiate hiPSCs to neuronal fates. The ability to differentiate,
culture, and manipulate human neurons is of tremendous interest
to labs seeking to study human neurodevelopment and neurolog-
ical diseases. For a group that is new to stem cell culture and
differentiation, the multitude of available neuronal differentiation
protocols can be overwhelming. Here, we aim to directly compare
some of the most commonly used techniques in human neuronal
differentiation, using gene expression, cell morphology, and
immunostaining to benchmark efficiency. We hope this study
may provide useful information to aid in other groups’ future
decisions regarding iPSC differentiation methods and reagents.
Many groups have taken advantage of somatic cell reprogram-
ming technology to generate patient-specific iPSC lines in order to
model neurodegenerative and neurodevelopmental disorders
(reviewed in [11]). Furthermore, there have been many advance-
ments in protocols to create neurons of a particular identity (e.g.
motor neurons, dopaminergic neurons or interneurons) [12–18].
There are often multiple protocols to differentiate stem cells to a
particular neuronal fate of interest. While a comparison of
neuronal patterning protocols would certainly be informative, it
is outside the scope of this study. Here, we focus on methods for
differentiating iPSCs to a ‘‘default’’ forebrain cortical neuronal
fate.
For the differentiation of iPSCs to forebrain neurons, two base
protocols are often utilized: an embryoid aggregate-based tech-
nique and a monolayer dual SMAD inhibition method [8,19]. In
the embryoid aggregate procedure, iPSC colonies in iPSC media
are allowed to form aggregates in suspension in the absence of
exogenous growth factors or small molecules. The media is then
changed at day 5 to a neural induction media with a DMEM/F12
base, containing non-essential amino acids, heparin, and N2
supplement, which supplies transferrin and insulin, among other
components (‘‘N2 neural induction media’’). The primitive
neuroectodermal aggregates are plated at day 7 onto an
adherence-promoting substrate, and cultured for 10 days,
promoting formation of definitive neuroectoderm. At day 17,
neural progenitor cells, organized into neural ‘‘rosette’’ structures,
are selectively removed from the plate and cultured in suspension.
These neural aggregates are cultured in a similar neural induction
medium, but with the addition of B27 supplement (containing
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biotin, DL alpha tocopherol, vitamin A, BSA, catalase, insulin,
transferrin, and superoxide dismutase, among other components),
cyclic AMP (cAMP), and insulin growth factor-1 (IGF-1) (‘‘N2/
B27 neural induction media’’). After being cultured in suspension
for 7 days, the neural aggregates are plated on an adherent
substrate in a differentiation-promoting media. This ‘‘neural
differentiation media’’ is made with a neurobasal base media
supplemented with non-essential amino acids, N2, B27, cAMP,
IGF-1, brain-derived neurotrophic factor (BDNF), and glial cell-
derived neurotrophic factor (GDNF). Differentiated neurons are
visible from day 25 onwards, and can be cultured as long as is
desired for experimental purposes [19]. There exist multiple
variations on this protocol, including aggregate formation
techniques, the use of different plating substrates, neural progen-
itor cell isolation methods, and co-culture of neuronal cells with
astrocytes.
The monolayer dual SMAD inhibition protocol [8] involves
dissociating iPSCs and plating them as a feeder-free adherent
monolayer before rapidly inducing neuroectoderm formation by
antagonizing the bone-morphogenetic protein (BMP) and trans-
forming growth factor beta (TGF-beta) signaling pathways (e.g. by
using Noggin and SB431542, respectively). The morphogen
Noggin and small molecule SB431542 induce conversion of
hiPSCs or hESCs to a neural progenitor cell fate by day 7, in a
neural induction media made with a DMEM/F12 base and
insulin, N2, and B27 (‘‘3N neural induction media’’) [10]. At day
11, cells are dissociated and re-plated in neural differentiation-
promoting media (‘‘neural differentiation media,’’ defined above).
Thus the media used by the dual SMAD inhibition protocol is
largely similar to those utilized in the embryoid aggregate method.
Two main differences exist between these two protocols: 1)
morphogens/small molecules block the BMP and TGF-beta
pathways in the dual SMAD inhibition protocol, and 2) the
monolayer (dual SMAD inhibition protocol) versus the three-
dimensional aggregate (embryoid aggregate technique) culture.
The resulting timelines of these methods are also distinct, with
neuroectoderm at day 17 vs. day 7, and neurons at day 25 vs. day
12 in the embryoid aggregate vs. dual SMAD inhibition protocols,
respectively.
Multiple studies have utilized each of these methods, often with
modifications, to generate human iPSC-derived neurons. These
variations involve the use of different reagents at multiple stages of
differentiation to achieve a common goal: culture of human
neurons. It is not always clear from a published study why a
particular method was chosen and how the method employed
compares to other available protocols. Here we examine both the
embryoid aggregate and dual SMAD inhibition protocols and
compare commonly used experimental paradigms for aggregate
formation, plating substrates, NPC isolation and expansion, and
neuronal maturation. We evaluate these various techniques
through the use of common metrics such as morphology,
immunostaining and gene expression.
Results
Differentiation of Human iPSCs Into Neurons Using an
Aggregate Method
To examine various differentiation strategies, we first utilized an
embryoid aggregate protocol [19] originally based on methods
developed for hESCs [20]. Fig. 1A shows the timeline schematic
for the protocol, in which human iPSCs are differentiated to
neuronal fates over the course of ,40 days. Aggregates were
formed by dissociating iPSCs as large clusters at day 1, followed by
suspension in culture for five days in serum-free iPS media
(without FGF2). At day 5, aggregate media was changed to N2
neural induction media. Aggregates then were plated on Matrigel
for the formation of primitive neuroepithelial cells (Fig. 1B, day
10) in N2 neural induction media. At day 17, neural rosette
structures were manually selected from plates and suspended in
flasks for another week in N2/B27 neural induction media. This
step aims to select for definitive neuroepithelial cells since many
non-neuroepithelia cell types adhere to the flask. At day 24,
aggregates were plated on Matrigel and allowed to mature for an
additional 15–30 days in neural differentiation media.
In order to qualitatively assess the progression of differentiation,
we performed immunostaining for various markers indicative of
the differentiation process (Fig. 1C). Undifferentiated iPSC
colonies expressed the pluripotent marker Oct4 (POU5F1), but
lacked expression of neuronal cytoskeletal markers such as MAP2.
The intermediate time-point day 18 shows the expression of neural
progenitor markers Sox1 and Nestin. Neurons differentiated for 40
days express neuronal proteins such as MAP2, TuJ1, and Tau, the
cortical marker Tbr1, and synaptic markers such as synaptophysin
(SYP) (Fig. 1C, bottom row). Functional analyses were performed
using a microelectrode array platform. Spontaneous potentials
were observed at around 50 days of differentiation, as previously
reported using this protocol [21]. In order to quantitatively assess
and compare differentiation progression across multiple wells,
qPCR was performed for multiple cell-fate markers (Fig. 1D).
Data show that with an increase in differentiation time, mRNA
expression of Oct4 (POU5F1) decreases, while neuronal markers
such as MAP2 and Tbr1 increase, and this expression pattern is
consistent between wells of the same experiment and between
differentiation rounds. To complement the qPCR data and
determine the absolute percentage of neuronal cells derived using
this method, the percentage of cells expressing MAP2 was
quantified from immunostained wells, with 93% (61.5 SEM) of
cells expressing MAP2 by day 40.
Generation of Neurons Utilizing Dual SMAD Inhibition in
Monolayer Culture
We next sought to compare a monolayer-based protocol to this
aggregate method. Fig. 2A illustrates the timeline schematic that
was utilized, based on the technique of dual SMAD inhibition [8].
At the start of differentiation (day 0), iPSCs were dissociated to
single cells and re-plated as a monolayer with a concentration of
20,000 cells/cm2 in MEF conditioned media, supplemented with
FGF2. After cells reached 90% confluency, media was changed to
3N neural induction media supplemented with Noggin (200 ng/
mL) and SB431542 (10 mM) [10]. Cells were split at day 11 using
dispase and re-plated in neural differentiation media onto 96-well
plates coated with Matrigel. The bright-field images in Fig. 2B
illustrate the morphological changes over the course of differen-
tiation. At day 7, the cells begin to form early rosette structures.
After re-plating the cells at day 11, small processes begin to emerge
(day 14), followed by more mature neuronal morphology at day 40
(Fig. 2B, last panel).
Both immunostaining and qPCR were employed to examine
differentiation efficiency over time. Cells begin to express
progenitor markers Sox2 and Pax6 at day 7 and Nestin and
Tbr2 at day 11. From its maximal expression at day 0, Oct4
expression is markedly decreased at day 11 (Fig. 2C). From day 27
through day 40, neuronal markers Tau, MAP2, Tbr1 and TuJ1
are expressed. Based on quantification of immunostaining,
approximately 45% (64.6 SEM) of cells expressed MAP2.
Similarly to the aggregate method, when we probed mRNA from
harvested cells, Oct4 (POU5F1) decreased over differentiation
time while MAP2 and Tbr1 increased up to day 40 (Fig. 2D).
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However, this method often resulted in ‘‘failed’’ differentiations
due to high levels of cell death between days 10–17 of
differentiation. Neuronal differentiation using the dual-SMAD
inhibition protocol without splitting led to cultures that either died
or did not produce MAP2+ neurons (10/10 differentiation
rounds), due to over-confluent cultures between days 10–17.
However with a revision in the protocol that included splitting the
cultures at day 11 (Chambers and Studer, personal communica-
tion), we observed MAP2+ cells in 3/5 differentiation rounds.
Based on these initial results, we chose to focus upon optimizing
the embryoid aggregate differentiation protocol.
Comparison of Embryoid Aggregate Formation: Manual
versus AggreWell
We hypothesized that differentiation efficiency could be
improved by creating embryoid aggregates of a more uniform
size, using AggreWell plates. At day 0, iPSCs were dissociated
manually using dispase and either resuspended in flasks or
triturated and plated in AggreWell plates. With AggreWell plates,
cells were force-pelleted into microwells by centrifugation. After 24
hours, dissociated cells formed aggregate structures and were
further cultured following the protocol outlined in Fig. 1A. We
made aggregates of two different types: 3,000 and 8,000 cells/
aggregate. Manually formed aggregates consisted of varying
shapes and sizes (Fig. 3A), whereas aggregates formed using
AggreWell were visually more uniform in size and shape. These
size differences were quantified by measuring the diameter of
aggregates (Fig. 3B). The mean diameter for manually formed
aggregates was 118.3 mm (66.0 SEM), whereas the mean
diameter was 183.1 mm (63.6 SEM) for 3,000 cells/aggregate
and 195.2 mm (65.5 SEM) for 8,000 cells/aggregate. Both sizes of
AggreWell aggregates were significantly larger than manually
formed aggregates, and although there was a trend for an
increased aggregate diameter between 3,000 and 8,000 cells/
aggregate, it did not reach statistical significance. As the
AggreWell system is designed to incorporate 3,000 versus
8,000 cells into each aggregate, the insignificant difference in
aggregate size may reflect a difference in aggregate density, with
8,000 cells/aggregate being more densely packed than 3,000 cells/
aggregate. Not surprisingly, the variance of aggregate size
distribution was significantly greater with manual aggregate
formation than with either AggreWell size. Immunostaining for
MAP2 in cells following aggregate formation with the use of
AggreWell is shown in Fig. 3C (right). Immunostaining at day 40
showed that approximately 46% (61.6 SEM) of AggreWell-
differentiated cells were MAP2+, compared to 93% MAP2+ cells
with manually formed aggregate differentiation. Quantification of
MAP2 mRNA from day 40 neurons that were cultured in the
AggreWell format also showed a corresponding significant
decrease in MAP2 mRNA levels (Fig. 3D).
Comparison of Plating Substrates: Matrigel vs. Poly-o-
laminin
The choice of plating substrates for differentiation varies among
labs and protocols. By far, the two most commonly used substrates
are Matrigel and a poly-ornithine/laminin combination (POL).
We sought to compare the results of using Matrigel versus POL
substrate at the two plating steps of the embryoid aggregate
technique (Fig. 1A). We found that using Matrigel for the first
aggregate plating (day 7) was sufficient to direct differentiation to a
neuroepithelial fate (Fig. 4A). However, when we attempted to
plate aggregates on POL at the same time-point, aggregates did
not reliably adhere to the plate (Fig. 4B). For the second plating of
neural aggregates at day 24, cells were plated on either Matrigel
(Fig. 4C) or POL (Fig. 4D). For both plating substrates, aggregates
were able to adhere to the plate, and cells with neuronal
morphology were visible. However, aggregates plated on POL
displayed sparser distribution of cell processes and more migration
of cell bodies away from aggregates (Fig. 4D) compared to
aggregates plated on Matrigel (Fig. 4C).
While plating aggregates for final differentiation induces
efficient neuron generation, for some purposes it may be desirable
to have a culture that is more monolayer in nature. For example,
aggregates can interfere with imaging as it is difficult to visualize
cells in or near large aggregates. In an effort to create a monolayer
cell culture, aggregates were dissociated with accutase at day 24
and plated on either Matrigel or POL (Fig. 4E, F).
Immunostaining of day 40 differentiated neurons (aggregates)
showed decreased MAP2 staining (Fig. 4G, bottom row) as well as
low levels of Tau staining, in POL versus Matrigel-plated neurons
(Fig. 4G, top row). TuJ1 staining appeared to be consistent
between the two plating conditions. MAP2 mRNA levels from day
40 differentiated neurons, plated on either Matrigel or POL, were
quantified using qPCR (Fig. 4H). Cells from POL-plated aggre-
gates expressed significantly less MAP2 mRNA than cells plated
on Matrigel. Based on immunostaining, approximately 56% (63.5
SEM) of differentiated neurons expressed MAP2 on POL,
compared to 93% MAP2+ cells with Matrigel plating.
Immunostaining of dissociated aggregates (single cells) revealed
similar results to those seen in Fig. 4G. Dissociated single cells
plated on POL exhibited less dense cultures than neurons plated
on Matrigel, with less overall staining of neuronal processes
(MAP2, Tau, TuJ1) (Fig. 4I, bottom row). MAP2 mRNA from
day 40 dissociated/single-cell neurons, plated on either Matrigel
or POL, was quantified using qPCR. Dissociated cells plated on
POL had significantly lower MAP2 mRNA expression than cells
plated on Matrigel (Fig. 4J).
Comparison of Neural Progenitor Cell (NPC) Isolation by
Multiple Methods
There are a number of ways to select desirable day 17
neuroepithelial rosette structures for further differentiation. We
next sought to compare different NPC isolation methods at day 17
Figure 1. Embryoid Body Differentiation of hiPSCs. A) Time course of differentiation for embryoid aggregates. iPSC colonies were dissociated
from mouse embryonic fibroblasts at day 1 (D1) and cultured as aggregates in suspension. Aggregates were plated onto culture dishes at day 7 (D7),
forming primitive neuroepithelial (NE) structures. By day 17 (D17), definitive NE structures were present; NE structures were manually isolated and
further cultured in suspension. Cells were plated for final differentiation at day 24 (D24). Arrows indicate media changes across differentiation. Boxes
indicate differentiation state. This protocol was performed in 11 independent lines, with all lines performing similarly; representative images are
shown. B) Bright-field microscopy images showing morphological changes spanning differentiation from the earliest time-point (iPSCs) to day 40
(D40) neurons. Scale bars from left to right: 100, 200, 200, 500, 500 mm. C) Cells were immunostained at various time-points during neuronal
differentiation. Confocal microscopy images at days 0 (iPS colony), 18, 26, and 40. Scale bars = 100 mm. TOPRO3, nuclear marker. D) qPCR analysis of
markers over differentiation. Ct data normalized to GAPDH. For Oct4: iPS n= 14, D17 n= 23, D40–50 n= 19 with data points all normalized to iPS;
MAP2: iPS n = 15, D17 n= 25, D40–50 n= 26 with data points all normalized to D40–50; Tbr1: iPS n = 14, D17 n= 25, D40–50 n= 26 with data points all
normalized to D40–50, from 6 independent differentiations. Data are represented as mean 6 SEM.
doi:10.1371/journal.pone.0105807.g001
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Figure 2. Monolayer Differentiation of hiPSCs. A) Time course of differentiation using dual-SMAD inhibition. iPSC colonies were dissociated
from mouse embryonic fibroblasts at day 1 (D1) and plated as a monolayer. Small molecules and growth factors were added as indicated. This
protocol was performed in at least 6 independent lines; representative images from the most efficient differentiations are shown. B) Bright-field
images spanning differentiation from the earliest time-point day 0 (D0) to day 40 (D40). Scale bars = 50 mm. C) Cells were immunostained at various
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of differentiation (Fig. 5A). First, manual neural rosette selection
was compared to enzymatic neural rosette selection. Manual
rosette selection involved manually scraping away the large, clear
cells (neural crest morphology) that surround neural rosette
structures to remove these contaminating cell types. For enzymatic
rosette selection, the StemCell Technologies STEMdiff Neural
Rosette Selection Reagent was used to selectively detach neural
rosettes from the dish (Fig. 5B). Immunostaining at day 18 (one
day after selection) shows that both manual and enzymatic rosette
selection enrich for Pax6+ (Fig. 5C, top row), Nestin+ (Fig. 5C,
top and bottom rows) and Oct42 (Fig. 5C, middle row) cells,
compared to cells that were not subjected to any NPC selection.
Manual selection resulted in fewer Oct4+ cells than rosette
selection (Fig. 5C, middle row). Sox2 expression was similar
between the three conditions, but there were several Sox2+/
Nestin2 cells without NPC selection, and a few Sox2+/Nestin2
cells after rosette selection (Fig. 5C, bottom row, asterisks).
Immunostaining of differentiated neurons at day 40 (after
enzymatic rosette selection) shows that 85% (65.1 SEM) are
MAP2+, similar to the 93% MAP2+ neurons resulting from
manual selection.
We hypothesized that employing a cell-sorting technique would
help decrease non-neuronal cell contamination in our cultures. To
test this, we sorted day 17 cells using magnetic affinity cell sort
(MACS) technology with a PSA-NCAM antibody. Manually
selected NPCs and PSA-NCAM+ cells were plated on Matrigel in
neural differentiation media for 23 days and immunostained for
various neuronal markers (Fig. 5D). Both conditions (manual
selection and PSA-NCAM+) expressed neuronal markers TuJ1,
MAP2 and Tau. However, sorted cells (Fig. 5D, right column) had
high background levels of non-neuronal cells, indicated by non-
neuronal morphology and absence of neuronal markers. Addi-
tionally, Tbr1 immunoreactivity was less abundant in MACS
preparations compared to manually selected cells (Fig. 5D, middle
row). Quantification following PSA-NCAM sorting from these
experiments showed 47% (62.3 SEM) MAP2+ cells.
Because MACS did not improve neuronal purity above other
NPC selection strategies, we then tested the ability of FACS to
enrich for NPCs by isolating CD184+/CD442/CD2712/
CD24+ cells using the BD Stemflow Human Neural Cell Sorting
Kit (based largely on [22]), wherein day 17 cells are dissociated
and labeled with these antibodies that mark specific cell
populations. CD184+/CD442/CD2712/CD24+ cells (‘‘NPCs’’)
and flow-through cells (‘‘non-NPCs’’) were maintained in neural
progenitor media for 20 days after sorting, followed by immuno-
staining for Nestin and MAP2 (Fig. 5E). This media, consisting of
a DMEM/F12 base with B27, FGF2, EGF, and heparin, supports
culture of adherent neural progenitor cells [23]. Fig. 5E shows that
FACS reduced the number of Nestin2/MAP22 cells present
(asterisks), but was highly stringent and also excluded some cells
expressing neuronal markers (arrowheads).
Finally, we compared the gene expression profiles of manual-,
rosette-, and FACS-isolated NPCs at day 17 by NanoString
(Fig. 5F, G). Gene expression analyses show that enzymatic rosette
selection appeared to be most permissive to other cell types, with
decreased expression of NPC markers FoxG1, HES1, Pax6,
Vimentin (VIM), and MAP2 (Fig. 5F), and higher expression of
non-NPC cell fate markers, including the endodermal marker
AFP (Fig. 5G). There was also a trend for increased expression of
pluripotent cell markers NANOG and Oct4 (POU5F1), but this
did not achieve significance. FACS-isolated NPCs showed similar
overall gene expression to manually isolated NPCs with a few
differences, including increased HES1 and decreased Tbr2
expression (Fig. 5F). Overall, these three NPC isolation methods
each enrich for neural progenitors, with slight differences in NPC
purity and identity.
Consequences of Neural Progenitor Expansion on
Neuronal Identity
Differentiation protocols are time-consuming and costly; thus,
we hoped to establish a protocol in which we could generate
neuronal cells from an expandable NPC pool. This would allow
for neuronal differentiation without differentiating cells for 17 days
prior to the NPC stage, and for expansion of neural progenitors for
increased neuronal yield. Fig. 6A shows the differentiation
schematic that was used to culture NPCs. Differentiation was
performed using the embryoid aggregate protocol (Fig. 1A) until
day 17. At day 17, neural rosettes were selected and isolated using
the Neural Rosette Selection Reagent from StemCell Technolo-
gies. Harvested cells were either maintained in suspension as
neural aggregates in N2/B27 neural induction media, plated for
expandable monolayer culture in neural progenitor media, or
plated on Matrigel in 96-well plates for final differentiation in
neural differentiation media.
We first compared neurons resulting from aggregates to neurons
differentiated from monolayer NPCs. Rosette-selected NPCs were
maintained on POL-coated plates in neural progenitor media with
EGF, FGF2, and heparin. Cells were plated for final neuronal
differentiation from a pool of monolayer-maintained NPCs after
the first or second passage (,3–5 days per passage) or directly
from day 24 aggregates without passaging. Cells were subsequently
maintained in neural differentiation media for 16 days (Fig. 6A).
Differentiation of monolayer-maintained NPCs from two subse-
quent passages showed a trend for decreased MAP2 mRNA
expression after the first passage and significantly lower MAP2
expression after the second passage compared to neurons derived
directly from day 24 aggregates (Fig. 6B). These data indicate
decreased potential for neuronal identity with extended monolayer
NPC expansion, which could result from expansion of contam-
inating adherent non-neuronal cells. We also observed a
corresponding decrease in MAP2 immunostaining in day 40
neurons derived from NPC monolayer passage 2 compared to
neurons derived from day 24 aggregates (Fig. 6C). We then
examined effects of suspension neural aggregate progenitor
expansion on resulting neuronal identity. NPCs were maintained
in suspension as neural aggregates for 2 days after selection (day
19) or 18 days after selection (day 35) before plating for final
neuronal differentiation. These cells were cultured in neural
differentiation media for 16 days before analysis of mRNA
expression by NanoString (Fig. 6D). Prolonged neural aggregate
culture did not appreciably alter resulting neuronal identity, as
demonstrated by comparable expression of cortical markers Satb1,
Tbr1, and Cux1 (Fig. 6D). However, the NPC/neural purity of the
cultures appeared to be improved with longer neural aggregate
culture, shown by higher nestin (Nes), Pax6, MAP2, and synapsin
(SYN) expression, as well as a trend for lower NANOG and Oct4
(POU5F1) expression (Fig. 6D). Thus, if long-term culture and/or
time-points during neuronal differentiation. Confocal images at days 0, 7, 11, 27 and 40. Scale bars = 100 mm. TOPRO, nuclear marker. D) qPCR analysis
of markers over differentiation. Data normalized to GAPDH. For Oct 4: iPS n = 3, D1 n= 3, D7 n= 3, D11 n= 6, D40 n= 5; MAP2: iPS n = 3, D1 n= 4, D7
n= 4, D11 n= 6, D40 n= 5; Tbr1: n = 2, D1 n= 3, D7 n= 3, D11 n= 5, D40 n= 5. Data are represented as mean 6 SEM.
doi:10.1371/journal.pone.0105807.g002
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expansion of NPCs is desired, maintenance in aggregates may be
superior to maintenance as a monolayer.
The Emergence of Endogenous Astrocytes
Neuronal markers change over the course of differentiation,
such that over time there is an upregulation of synaptic markers.
We also were interested in whether endogenous astrocytes
emerged in our cultures within 100 days of differentiation
(Fig. 7A, green arm). Immunostaining and confocal microscopy
of day 42 and day 100 neuronal cultures showed an increase in
expression of glial fibrillary acidic protein (GFAP), a marker of
astrocytes, at day 100 (Fig. 7B). Additionally, using the Nano-
String platform, we evaluated RNA harvested from either day 40
or day 100 neuronal cultures for a subset of neuron and astrocyte
markers (Fig. 7C) and synaptic markers (Fig. 7D). Day 100
cultures showed a significant increase in expression of the
astrocytic markers GFAP and S100B (Fig. 7C), as well as in
markers of mature neurons, VGLUT1 (SLC17A7), NMDAR and
KCC2 (Fig. 7D). There was no significant difference in MAP2,
Tbr1, Tau, SYN, PSD95, or VGAT between day 40 and day 100
cultures.
Neuronal Maturation with Astrocyte Co-culture
Lastly, we aimed to address the possible benefits of astrocyte co-
culture on differentiation, i.e. if we could accelerate maturation of
neuronal cultures before day 100. Differentiated neurons were
cultured alone or co-cultured with mouse astrocytes (Sciencell)
after plating at day 24 (Fig. 7A, purple arm). Samples were
harvested at day 40, before the emergence of endogenous
astrocytes. By immunostaining, there were no qualitative differ-
ences in MAP2 or SYP expression between culture conditions
(Fig. 7E). However, we were able to visualize protein expression of
VGLUT1 at day 40 only when differentiated neurons were co-
cultured with exogenous astrocytes (Fig. 7E, bottom row). qPCR
analysis showed no changes in MAP2, Tbr1, CUX1, GAD1 or
SYP expression, but significantly increased VGLUT1 (SLC17A7)
expression at day 40 with astrocyte co-culture (Fig. 7F).
Discussion
With advancements in iPSC neuronal differentiation, it has
been possible to examine human neural development and
consequences of neurological disease-associated mutations at the
cellular level. However, there exist a multitude of techniques to get
from point A (iPSCs) to point B (differentiated neurons). Here, we
evaluated several methods that are regularly used to generate
forebrain cortical neurons, the ‘‘default’’ neuronal fate generated
in the absence of exogenously provided patterning factors. We
compared the outcomes of these protocols using gene expression,
cell morphology, and protein expression by immunostaining
(Table 1). Notably, these protocols resulted in robust expression
of forebrain cortical transcription factors with negligible expression
Figure 3. Comparison of Embryoid Body Formation. A, B)
Embryoid bodies were either formed by dissociating iPSCs (using
dispase and trituration) or by AggreWell plate technology, followed by
culture in non-adherent flasks. B) Quantification of aggregate size from
manually-formed or 3,000- or 8,000-cell aggregates. Mean diameter for
manually formed aggregates = 118.3 mm; mean diameter for 3,000 cells/
aggregate = 183.1 mm; mean diameter for 8,000 cells/aggrega-
te = 195.2 mm. Scale bars = 200 mm. Data are represented as mean 6
SEM, from 4 independent differentiations, n = 21–43. Significance
determined by one-way ANOVA with a Tukey’s post-test: ***, p,
0.0001. F-tests between groups showed significantly different variances,
with p,0.05 between manual vs. 3,000 cells/aggregate and manual vs.
8,000 cells/aggregate. C) Immunostaining of day 40 (D40) neurons,
following differentiation using either manual formation or AggreWell
plates. TOPRO, nuclear marker. Scale bars = 100 mm. Representative
images are shown. D) qPCR was performed using RNA harvested from
day 40 cultures. Data normalized to GAPDH expression. Manual n = 10,
AggreWell n = 10. Data are represented as mean 6 SEM. Significance
was determined by student’s t-test: ***, p,0.0001.
doi:10.1371/journal.pone.0105807.g003
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of midbrain and hindbrain transcription factors, as assessed by
NanoString counts (Figure S1).
The percentage of cells expressing MAP2 was quantified
following immunostaining from many of the various differentiation
schemes employed here. The manual embryoid aggregate method
with manual rosette selection as well as enzymatic rosette selection,
generated the highest percentage of MAP2+ cells at day 40 of
differentiation (,93% and ,85%, respectively). Other differen-
tiation methods resulted in significantly fewer MAP2+ cells, such
as monolayer dual SMAD inhibition differentiation (,45%),
AggreWell embryoid aggregate differentiation (,46%), and PSA-
NCAM sorting (,47%). It has been reported that different iPSC
lines can vary in their ability to differentiate into neural cells
[9,24–31]. For the embryoid aggregate-based differentiation
variations examined herein, we did not observe obvious differences
in efficiency of final neuronal differentiation or cell isolation
method across cell lines. As this protocol includes steps to
minimize or exclude undesirable cell types (e.g. selection of NPCs
at day 17 and subsequent NPC culture in suspension), differences
in differentiation capacity of different lines are minimized.
However, we did note that certain lines differentiated better than
others using the dual-SMAD inhibition protocol, with the most
promising neuronal differentiations shown here (Table 2).
At both plating steps of the embryoid aggregate protocol,
Matrigel appears to be a superior substrate for promoting cell
adherence and acquisition of neuronal identity. Use of Matrigel in
the second plating generates .90% MAP2+ cells at day 40 of
differentiation, compared to 56% MAP2+ cells using POL for the
second plating. Plating cells on Matrigel at the second step leads to
higher MAP2 mRNA expression compared to the POL plating,
despite whether the cells are plated as aggregates or dissociated
and plated as a monolayer. Matrigel likely serves as a better
substrate due to its complex composition, which includes laminin,
collagen IV and entactin, as well as a variety of growth factors that
may promote neuronal differentiation. Notably, we have found
that the lot-to-lot variability in Matrigel protein concentration is
important for its differentiation- and adherence-promoting capa-
bility in the second plating step. Matrigel lots with higher initial
protein concentrations are often more suitable for neuronal
differentiation, even when plated at the same absolute protein
levels.
Isolation of NPCs may be done by a variety of methods, four of
which we compared here: manual selection, enzymatic rosette
selection, PSA-NCAM MACS, and FACS. PSA-NCAM sorting
was less effective than manual NPC selection, with decreased
neuronal purity in PSA-NCAM+ sorted populations. Each of the
remaining methods serves to enrich for NPCs, with some
differences. Rosette selection appears to be more permissive to
undesirable cell types, including pluripotent cells and endodermal
cells, than manual selection or FACS. However, this method still
generates neurons with high purity. The increased HES1
expression with FACS could reflect increased purity of prolifer-
ative, undifferentiated neuroepithelial cells with FACS isolation
[32,33]. Decreased Tbr2 expression with FACS isolation suggests
that this method may enrich for earlier neural progenitors at the
expense of decreased enrichment for intermediate progenitors
[34].
The less selective nature of the neural rosette selection reagent
should be balanced with the cost (in both time and money) of each
method. The manual selection method can be the most time-
consuming and requires an experienced user, but requires no
additional reagents and thus has the lowest reagent cost. The
rosette selection method is fastest, but requires use of a proprietary
reagent and so comes with a moderate cost. Finally, FACS
selection is somewhat time-consuming and is the most expensive
method. FACS also greatly reduces the total yield of viable cells, as
there is significant cell loss due to prolonged dissociation and
sorting time. The decision to choose one of these methods should
be determined by the experimental setup and subsequent use of
the isolated NPCs. If a highly sensitive and/or expensive method
will be used on the isolated NPCs and purity is of the utmost
importance, FACS isolation may be optimal. For experiments with
few cell lines, manual selection is the cheapest and most effective
method. If many different hiPSC lines are being differentiated,
manual rosette selection would be time-prohibitive and rosette
selection may be a better option. For an experiment in which
NPCs will be further purified as neural aggregates (where many
non-NPC fates will adhere while NPCs float as aggregates), rosette
selection should be acceptable.
Culturing cells as NPCs has the advantage of expanding the
neural progenitor pool for subsequent neuronal differentiation
without having to repeat days 1–17 of differentiation. This can
save time and resources while increasing neuronal yield per
differentiation experiment. If expansion of cells at the NPC stage is
desired, our data suggest that maintenance as neural aggregates is
superior to maintenance in a monolayer. Differentiation of later
passage cells from aggregates show increased purity without
obvious alterations in neuronal identity (as assayed by our 150-
probe NanoString profile), whereas extended culture in monolayer
decreased neuronal identity of the resulting cells. This may be
related to the suspension nature of aggregate culture, wherein
many contaminating cell types (e.g. neural crest cells) will
preferentially adhere to the flask, whereas desirable cell types
(e.g. NPCs) will be maintained as suspended aggregates. There
also is a possibility that the slightly different media formulations of
N2/B27 neural induction media versus neural progenitor media
may alter cell fate and differentiation capacity (e.g. N2, cAMP,
IGF-1 only in the former and FGF2, EGF only in the latter). Of
note, neural aggregate size increases as cells proliferate, which
eventually limits nutrient access for cells inside the aggregate. To
allow cells to continue proliferating while maximizing access of
cells to nutrients, neural aggregates can be broken up by gentle
Figure 4. Comparison of Plating Substrates. Aggregates were plated on either Matrigel or poly-o/laminin (POL) coated plates at days 7 or 24. A,
B) Aggregates plated at day 7 (D7) and imaged at day 10 (D10) on Matrigel (A) formed typical neuroepithelial structures, while aggregates plates on
POL (B) failed to adhere after two days. C, D) Aggregates were plated on either Matrigel or POL coated plates for final differentiation on day 24 (D24)
and imaged at day 40 (D40). Aggregates plated on Matrigel (C) exhibited an increased density of processes, while aggregates plates on POL (D)
displayed increased cell body migration from the plated aggregate. E, F) Neural aggregates were dissociated at day 24 and plated on either Matrigel
(E) or POL (F). G) Aggregates were plated on either Matrigel (top row) or POL (bottom row) at day 24 and allowed to mature until day 40, followed by
immunostaining and confocal microscopy for neuronal markers. Scale bars = 100 mm. Representative images are shown. H) qPCR was performed
using RNA harvested from day 40 cultures. Data normalized to GAPDH expression. Matrigel n = 10, POL n=10. I) Aggregates were single-cell
dissociated and plated on either Matrigel (top row) or POL (bottom row) at day 24 and allowed to mature until day 40, followed by immunostaining
and confocal microscopy for neuronal markers. Scale bars = 100 mm. Representative images are shown. J) qPCR was performed using RNA harvested
from day 40 cultures. Data normalized to GAPDH expression. Matrigel n = 22, POL n= 22. For H and I, significance determined by student’s t-test: **,
p,0.01; ***, p,0.001. Data are represented as mean 6 SEM.
doi:10.1371/journal.pone.0105807.g004
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Figure 5. Comparison of NPC isolation methods. A) Schematic indicating the time course of differentiation and the techniques used to isolate
neural progenitor cells (NPCs). Human iPSCs were differentiated for 17 days. NPCs were isolated by manual scraping of non-NPCs under a microscope
(manual selection), using a proprietary neural rosette selection reagent (rosette selection), or by FACS for CD184+/CD442/CD2712/CD24+ cells
(FACS). B) Representative bright field images are shown for selection of rosettes using rosette selection reagent. White arrows indicate rosette
structures to be isolated. After use of the reagent, rosettes are isolated. Scale bars = 100 mm. C) Immunostaining for various cell fate markers at day 18
after isolation at day 17. Asterisks in the bottom panel show Sox2+Nestin2 cells. Scale bars = 100 mm. D) Day 17 NPCs were either manually selected
or dissociated using accutase and processed for cell sorting. Manually selected or PSANCAM+ cells were plated on Matrigel for 23 days in neural
differentiation media and immunostained at day 40 for neuronal markers. Scale bars = 100 mm. E) Day 17 cells were dissociated and subjected to
FACS. CD184+/CD442/CD2712/CD24+ cells (‘‘NPCs’’) and all other cells (‘‘non-NPCs’’) were plated on Matrigel and maintained in neural progenitor
media for 20 days prior to immunostaining. Scale bar = 50 mm. F, G) RNA was harvested from cells at day 17 after isolation and used in the NanoString
assay. Expression profiles of selected NPC fate markers (F) or other cell fate markers (G) are shown. Gene expression was normalized to the geometric
mean of seven housekeeping genes. Data are represented as mean 6 SEM. Data are from 5–6 independent differentiations and 3 lines, n = 6–30.
Significance is shown compared to ‘‘manual selection.’’ Statistics were calculated using two-way ANOVA with Holm-Sidak multiple comparisons
correction: *, p,0.05; **, p,0.01; ***, p,0.001.
doi:10.1371/journal.pone.0105807.g005
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trituration [12]. Other groups have reported the establishment of
NPC lines from hESCs or hiPSCs, often using more than one
purification strategy to generate a highly pure and homogenous
NPC population [23,35–41]. These strategies could be considered
to generate NPC lines for longer-term use, but it is less sustainable
to execute multiple purification techniques for many lines over
multiple differentiations.
We also sought to study the emergence of endogenous astrocytes
from neuronal cultures and examine the effect of exogenous
astrocytes on iPSC-derived neurons. Over differentiation time,
remaining neural progenitor cells begin to produce astrocytes,
shown by increasing astrocyte marker expression and immuno-
staining by day 100. This confirms data presented by other groups
showing emergence of astrocytes with long-term differentiation of
hiPSC-derived neural progenitors [42–44]. Concurrently, there is
an increase in the excitatory neuronal marker VGLUT1
(SLC17A7) (but not SYN) expression. Co-culture of human
iPSC-derived neurons with mouse astrocytes promoted increased
expression of VGLUT1 (SLC17A7) at day 40, without affecting
other neuronal subtype and synaptic markers. This suggests that
exogenous astrocyte co-culture promotes the maturation of iPS-
derived neurons without altering cell fate. These data are
consistent with reports of accelerated hESC- and hiPSC-derived
neuronal maturity with astrocyte co-culture [45,46]. Addition of
exogenous astrocytes has the advantage of accelerating neuronal
maturation, which may be desirable depending on the phenotype
to be studied.
Achieving a ‘‘standard’’ protocol for neural differentiation
across laboratories is unrealistic, due to the wide range of studied
phenotypes and continual development of new protocols. Because
Figure 6. Effects of Neural Progenitor Cell Maintenance and Expansion on Differentiation Efficiency. A) Schematic indicating the time
course of differentiation and the techniques used to maintain/differentiate neural progenitor cells (NPCs) after NPC isolation with neural rosette
selection reagent at day 17. B) qPCR analysis of MAP2 expression after 16 days of differentiation of day 24 aggregates or passage 1 or 2 monolayer
NPCs. Data normalized to GAPDH. Data are represented as mean 6 SEM, n = 11–20. C) Immunostaining of day 40 (D40) neurons, following
differentiation from either day 24 aggregates or passage 2 NPCs. Scale bars = 100 mm. Representative images are shown. D) NanoString analysis of
cell fate markers of neural aggregates plated at day 19 or 35, after 16 days of plating in neural differentiation media, normalized to the geometric
mean of seven housekeeping genes. Data are represented as mean 6 SEM, n= 6. For B and D, significance was determined by student’s t-test: *, p,
0.05; **, p,0.01; ***, p,0.001.
doi:10.1371/journal.pone.0105807.g006
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Figure 7. Astrocyte Co-culture Increases Neuronal Maturation and Endogenous Astrocytes Arise at Later Time-Points in
Differentiation. A) Schematic of differentiation up to 100 days. For astrocyte co-culture, astrocytes were added to neuronal cultures at ,day 24 of
differentiation. Endogenous astrocytes gradually emerged over the course of 100 days, after day 40. B) Day 42 and day 100 neuronal cultures were
immunostained and imaged for GFAP. Scale bars = 50 mm. C) After 40–50 (D40) or 100 days (D100), cells were lysed, RNA extracted, and expression of
150 genes analyzed using the NanoString platform. A subset of neuronal markers (C) and synaptic markers (D) are shown. Data are from at least 6
independent differentiations (3 lines). For day 40–50 n= 29–38, for day 100 n= 15–19. E) Neuron cultures with or without astrocytes were
immunostained and imaged using confocal microscopy at day 40. Insets in right column show VGLUT1 staining along the length of a neuronal
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small variations in methods can have dramatic effects on the
resulting cells (and studied cellular properties), it is imperative that
groups utilizing iPSC-derived neural cells carefully report how
differentiation was performed and thoroughly characterize the
resulting cell populations. The data included here provide a
framework upon which researchers can base decisions regarding
differentiation protocols. We hope this may aid in selection of
optimal protocols, promote awareness of the many variables that
can affect differentiation, and encourage detailed reporting of
differentiation methods in published studies.
Experimental Procedures
iPSC Reprogramming and Generation. Human iPSCs
were obtained from the UCONN Stem Cell Core. Lines YK26,
YZ1 and TZ1 were generated by retroviral vectors containing the
reprogramming factors OCT4, SOX2, NANOG and LIN28 or c-
Myc and KLF4 [19]. Additional lines were reprogrammed by
retroviral vectors containing the reprogramming factors OCT4,
SOX2, c-Myc and KLF4 in conjunction with the Harvard Stem
Cell Institute as previously described [21].
iPSC Karyotype Analysis and Characterization. The
NanoString nCounter Human Karyotype Panel CNV CodeSet
was used to assay iPSC genomic DNA every ,10 passages in
order to ensure a stable chromosome number over time.
iPS Cell Culture. iPSCs were cultured in iPSC media as
previously described [21]. FGF2 (Millipore) was added fresh daily
at 10 ng/ml. Cells were maintained at 37uC/5% CO2 and were
split as necessary based on colony growth (,6 days). iPSCs were
manually groomed by removing any colonies with irregular
borders, spontaneous differentiation or transparent centers, prior
to splitting. iPSCs were maintained on a mouse embryonic
fibroblast (MEF) feeder layer at 1.7–2.06105 cells/well of a 6-well
plate (Globalstem).
Embryoid Aggregate Differentiation Protocol. For the
induction of forebrain neurons, iPSCs were differentiated using an
embryoid body-based protocol [19], further optimized here.
Colonies with irregular borders, spontaneous differentiation or
transparent centers were removed prior to splitting. iPSC colonies
were dissociated from MEFs at day 1 with collagenase (StemCell
Technologies) and cultured as aggregates for 4 days in suspension
with iPSC media (no FGF2), with media changes every day. At
day 5, aggregates were washed 1X with N2 Neural Induction
media and then fed with N2 Neural Induction media. On day 7,
aggregates were plated on either Matrigel-coated culture dishes
(used per the manufacturer’s instructions, BD Biosciences) or poly-
ornithine (4 mg/cm2) and laminin-coated plates (1 mg/cm2), at
about 20–30 aggregates/well. Cells were fed every 2 days with N2
Neural Induction media. Over the course of 10 days, primitive
neuroepithelial (NE) structures were formed. By day 17 definitive
NE structures were present and rosettes selected.
Neural Rosette Selection. Neural rosettes were selected
manually, selected with STEMDiff Neural Rosette Selection
reagent (used per the manufacturer’s instructions, StemCell
Technologies), or purified by MACS/FACS (further information
below). For manual selection, cells with non-rosette morphology
were scratched off culture plates using either sterile glass pipettes
or sterile plastic pipette tips, followed by aspiration of undesirable
material. Remaining rosettes were then scraped from the plate for
further use. For each selection method, neural progenitor cells
(NPCs) were either dissociated and plated for further differenti-
ation or re-cultured in non-adherent culture flasks. Alternatively,
NPCs were cultured as an adherent monolayer.
Neural Progenitor Cell Monolayer Culture. NPCs were
maintained in neural progenitor media (+FGF2, EGF, heparin)
and passaged 1:3 every 3–5 days or as necessary when confluent.
Cells were split onto poly-ornithine (4 mg/cm2) and laminin (1 mg/
cm2) coated plates. Plates were coated overnight in a humidified
37uC incubator.
Neural Aggregate Culture. After NPC selection, cells were
cultured in suspension and fed with N2/B27 neural induction
media with cAMP and IGF-1. At day 24 (or as otherwise noted)
cells maintained as aggregates were either plated as aggregates (3–
5 aggregates/well of 96 well plate) or dissociated to single cells with
accutase (Invitrogen) (40,000–50,000 cells/well of 96 well plate)
and plated on Matrigel for final differentiation in Neural
Differentiation media with ROCK inhibitor (Stem RD, 10 mM).
Cells plated at day 17 were also switched to neural differentiation
media at day 24 for the remainder of the experiment. A full media
change was performed every 2–3 days.
Astrocyte Co-culture. Mouse astrocytes (Sciencell) were
plated on top of differentiated human neurons at day 26 in a
1:1 media mix of Neural Differentiation media and Astrocyte
media (Sciencell). Approximately 120,000 cells/cm2 were plated.
Prior to plating, mouse astrocytes were maintained per the
manufacturer’s directions.
Monolayer Differentiation Protocol. Using an alternate
method for the induction of forebrain neurons, iPSCs were
differentiated using a monolayer protocol [8,10]. iPSCs were
manually groomed by removing any colonies with irregular
borders, spontaneous differentiation or transparent centers. To
initiate differentiation, cells were dissociated with accutase
(Invitrogen) for 30 minutes at room temperature. The cells were
then triturated to form a single cell suspension and subsequently
filtered through a 0.45 mm cell strainer to remove any cell clumps.
Remaining cells on the plate were rinsed with additional iPSC
media. Cells were washed and centrifuged (200 g, 5 minutes) 2x
and then resuspended in 10 mL iPSC media with ROCK
inhibitor (StemRD, 10 mM). The cell suspension was then plated
on a pre-coated gelatin 10 cm plate, with a density of less than
200,000 cells/cm2. 10 cm dishes were then incubated at 37uC for
30 minutes to allow MEFS time to adhere to the gelatin, without
substantial adherence of iPSCs. After 30 minutes, suspended cells
were washed with iPSC media + 10 mM ROCK inhibitor and
centrifuged (200 g, 5 minutes). Collected cells were resuspended
with MEF conditioned media + 10 mM ROCK inhibitor. Cells
were re-plated as a monolayer with a concentration of 20,000
cells/cm2 in MEF conditioned media, supplemented with FGF2
(10 ng/mL). After cells reached 90% confluency, media was
changed to 3N neural induction media (defined below) supple-
mented with Noggin (200 ng/mL) and SB431542 (10 mM) [10].
Cells were split at day 11 using dispase and re-plated in neural
differentiation media onto 96-well plates coated with Matrigel.
Aggregate formation using AggreWell. Aggregates were
formed using either 400 or 800 mm well plates. Plates were used
per the manufacturer’s instructions to form aggregates of either
3,000 or 8,000 cells/aggregate. 24 hours after AggreWell plating
process. Representative images are shown. Scale bars = 50 mm. F) qPCR was performed using RNA harvested from day 40 cultures. Data normalized to
GAPDH expression. For neurons alone n= 20 for MAP2, TBR1, CUX1, GAD1, n = 37 for SYP, n = 38 for VGLUT1; for astrocyte co-culture n = 17 for GAD1,
n = 18 for MAP2, TBR1, CUX1, n = 27 for SYP, n = 25 for VGLUT1. For C–F, data are represented as mean6 SEM. Significance determined by student’s t-
test: **, p,0.01; ***, p,0.001; ****, p,0.0001.
doi:10.1371/journal.pone.0105807.g007
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(day 2), aggregates were resuspended in low-adherence flasks and
cultured in the appropriate medias listed above.
Medias
MEF Medium. 435 mL DMEM (Invitrogen), 5 mL 100x
Penicillin/Streptomycin (Invitrogen), 5 mL 100x L-glutamine
(Invitrogen), 50 mL FBS (Invitrogen).
iPS Medium. 390 mL DMEM/F12, 100 mL KOSR (Invi-
trogen), 5 mL 100x Penicillin/Streptomycin/Glutamine (Invitro-
gen), 5 mL 100x MEM-NEAA (Invitrogen), 50 mM b-mercapto-
ethanol (Invitrogen), with the addition of fresh FGF2 (Millipore,
10 ng/mL) to the medium.
N2 Neural Induction Medium. 490 mL DMEM/F12
(Invitrogen), 5 mL N2 supplement (Invitrogen), 5 mL 100x
MEM-NEAA (Invitrogen), and Heparin (Sigma-Aldrich, 2 mg/
mL).
N2/B27 Neural Induction Medium. 480 mL DMEM/
F12, 5 mL N2 supplement (Invitrogen), 10 mL B27 supplement
(Invitrogen), 5 mL MEM-NEAA (Gibco) and 2 mg/ml Heparin
(Sigma-Aldrich), with the addition of fresh cAMP (1 mM) (Sigma)
and IGF1 (PeproTech, 10 ng/mL) to the medium.
Neural Differentiation Medium. 490 mL Neurobasal me-
dium (Invitrogen), 5 mL N2 supplement (Invitrogen), 5 mL 100x
MEM-NEAA (Invitrogen), and 10 mL B27 supplement (Invitro-
gen), with the addition of fresh cAMP (Sigma, 1 mM), BDNF,
GDNF, and IGF-1 (all PeproTech, 10 ng/mL) to the medium.
Neural Progenitor Medium. 350 mL DMEM (Invitrogen),
150 mL F12 (Invitrogen), 5 mL 100x sodium pyruvate (Invitro-
gen, only if not included in DMEM formulation), 5 mL 100x
Penicillin/Streptomycin/Glutamine (Invitrogen), 10 mL B27 sup-
plement (Invitrogen) with the addition of fresh EGF (Sigma,
20 ng/mL), FGF2 (Millipore, 20 ng/ml), and heparin (Sigma,
5 mg/ml) to the medium.
MEF Conditioned Medium. 2.8610‘6 mouse embryonic
fibroblasts (GlobalStem) were plated on a gelatin-coated dish (1
hour at room temperature) in MEF media. 24 hours later, cells
were washed 1X with iPS media and fed with fresh iPS media.
Media was incubated for 24 hours and then collected. Additional
iPS media was conditioned every 24 hours for up to 2 weeks. All
media was pooled and sterile-filtered before use. 10 ng/mL of
FGF2 was added fresh before use.
3N Neural Induction Medium. 485 mL DMEM/F12, 5 ml
100x MEM-NEAA (5 mg/mL), 5 mL N2 supplement (Invitrogen),
10 mL B27 supplement (Invitrogen), insulin (Sigma, 5 mg/mL),
50 mM b-mercaptoethanol (5 mg/mL), 5 mL 100x Penicillin/
Streptomycin/Glutamine (5 mg/mL).
qPCR
RNA was purified from individual samples and processed
through a PureLink RNA Mini Kit (Ambion), followed by reverse
transcription using SuperScript II (Invitrogen). qPCR was
performed using Fast SYBR Green Master Mix (Applied
Biosystems) and run on a ViiA 7 System (Applied Biosystems).
Table 1. Key comparisons of methods tested.
Optimization Parameter Key Benchmarks Results Notes
Differentiation Protocols
Embryoid Aggregate
vs. Monolayer Dual
SMAD Inhibition
MAP2%, qPCR of
neuronal markers
Consistent neuronal yield with over 90%
MAP2+ neurons using embryoid aggregate
protocol. Decreased MAP2% with dual
SMAD inhibition method.
Zeng et al., 2010 [19]; Chambers et al., 2009 [8]
Aggregate Formation
Manual vs. AggreWell MAP2%, qPCR of
neuronal markers,
brightfield microscopy
Manual formation more variable in aggregate
size than Aggrewell. More consistent
aggregate size and decreased MAP2% using
Aggrewell
Zeng et al., 2010 [19]; StemCell Technologies
Plating Substrates
Matrigel vs. POL MAP2%, qPCR of
neuronal markers,
immunostaining of
NPC and iPSC markers
Matrigel promotes aggregate adherence
better than POL at D7. Matrigel generates
higher percentage of cortical neurons than
POL at D40.
Matrigel from BD Biosciences. Lot-to-lot variations in
protein content may affect outcome.
Progenitor Selection
Manual/Cell
Sort/Rosette
Selection
MAP2%, immunostaining
of neuronal markers,
Nanostring of NPC
and non-neuronal
markers
Rosette Selection is rapid and efficient but
most permissive to non-neural cells. FACS
and manual selection are equally effective
for eliminating non-neural cells, but FACS is
more time-consuming, has a lower yield,
and selects NPCs with slightly different
marker expression.
Manual: Zeng et al., 2010 [19]; Hu et al. 2010 [9];
FACs: BD Biosciences, Yuan et al., 2011 [22]; Rosette
Selection: StemCell Technologies
Co-culture
None vs. Astrocytes qPCR of neuronal
markers, Nanostring
of neuronal and
astrocyte markers,
immunostaining of
neuronal markers
Astrocyte-free cultures express neuronal
markers, but express less VGLUT1 than
co-culture with astrocytes or cultures
containing endogenous astrocytes
doi:10.1371/journal.pone.0105807.t001
Comparing hiPSC Neuronal Differentiation Protocols
PLOS ONE | www.plosone.org 14 August 2014 | Volume 9 | Issue 8 | e105807
Samples were assayed with 3 technical replicates. Data was
analyzed using the DDCT method and expression was normalized
to GAPDH expression [47]. Primer efficiency was calculated for
each pair of primers and the slope of the dilution line was found to
be within the appropriate range. Dissociation curves also showed
single peak traces, indicating template-specific products.
Primers
Oct4- Forward: TGGGCTCGAGAAGGATGTG; Reverse:
GCATAGTCGCTGCTTGATCG
MAP2- Forward: AACCGAGGAAGCATTGATTG; Reverse:
TTCGTTGTGTCGTGTTCTCA
Tbr1- Forward: TCACCGCCTACCAGAACAC; Reverse:
GTCCATGTCACAGCCGGT
GAPDH- Forward: GGGAGCCAAAAGGGTCATCA; Re-
verse: TGGTTCACACCCATGACGAA
CUX1- Forward: GATGCCACCGCAACGGTAT; Reverse:
GGACTGCTCACTTTCATCCTG
VGLUT1- Forward: ACTCAGCTCCAGCGTCTCC; Re-
verse: GAGTTTCGGAAGCTAGCGG
GAD1- Forward: AGGAGAGGCAATCCTCCAAGA; Re-
verse: ATCCCGGTCGCTGTTTTCAC
SYP- Forward: AGGGAACACATGCAAGGAG; Reverse:
CTTAAACACGAACCACAGG
NanoString analysis
We utilized a custom 150 gene probe set designed by
NanoString Technologies (nCounter Gene Expression Assay) to
analyze gene expression for a large number of genes from an
individual sample. All assays were performed following Nano-
String protocols. The initial hybridization reactions were carried
out with 100–1000 ng RNA. Post-hybridization samples were
processed using the nCounter Prep-station. Following run
completion, the cartridge was scanned at max resolution (,1000
images/sample) using the nCounter Digital Analyzer. Data were
analyzed using the nSolver Analysis Software and normalized to a
set of 7 house-keeping genes (HK) or to the total gene set, as noted.
HK genes: GAPDH, GUSB, HPRT1, LDHA, POLR2A,
RPL13a and RPL27. Probe sequences are listed in Table 3.
Antibodies
Immunostaining was performed with the following antibodies:
Abcam: [MAP2 (1:5000), Oct4 (1:1000), Tbr1 (1:200), Sox2
(1:1000), SYP (1:250), VGLUT1 (1:500), GFAP (1:1000)];
Millipore, Tbr2 (1:500); Dako, Tau (1:200); Sigma, TuJ1
(1:1000); R+D, Nestin (1:1000); Covance, Pax6 (1:300) and Novus,
Sox 1 (1:200). Secondary antibodies were supplied by Jackson
ImmunoResearch: anti-chicken Cy2/Cy3/Cy5, anti-rabbit Cy2/
Cy3, anti-mouse Cy2/Cy3. Invitrogen, TOPRO3 & DAPI
(nuclear markers, 1:1000).
Immunocytochemistry and microscopy
Cultures were fixed with 4% paraformaldehyde, followed by
membrane permeabilization and blocking with 0.1% Triton X-
100 in donkey serum (Jackson ImmunoResearch). Samples were
incubated with primary and secondary antibodies (see Antibodies)
overnight and 1 hour, respectively. Imaging was performed using a
Zeiss LSM710 confocal microscope and images were acquired
using ZEN black software. Software was used to pseudo-color
images and add scale bars. Quantified MAP2 immunostaining was
performed blind on at least 3 images per condition, with at least
200 cells counted per image, using ImageJ software (NIH).
MACS
Day 17 embryoid aggregate-differentiated cells were utilized for
MACS. Cells were dissociated to single cells using accutase
(Invitrogen) +10 mM ROCK inhibitor (StemRD) for 30–45 min-
utes. Cell clumps were removed using a 70 mm strainer (Pre-
separation filter, Miltenyi). Cells were sorted per the manufactur-
er’s instructions using Anti-PSA-NCAM Microbeads (Miltenyi)
and related equipment (MS columns and MACS Separator,
Miltenyi).
FACS
Day 17 embryoid aggregate-differentiated cells were utilized for
FACS. Cells were dissociated using accutase (Invitrogen) for
25 minutes and treated per the manufacturer’s protocol (Human
Neural Cell Sorting Kit, BD Biosciences). The kit was used to
isolate CD184+/CD442/CD2712/CD24+ neural stem cells,
which were separated from neural crest and other non-neuronal
Table 2. Number of iPSC lines, differentiations and well numbers contributing to each figure.
Figure Lines used
Independent
differentiations n
Figure 1 YZ1, TZ1,
YK26, fAD 2a
1D: 6 1D: iPS n = 14–15, D17 n = 23–25, D40–50 n = 19–26
Figure 2 YZ1, YK26 *2D: 2 *2D: iPS n= 2–3, D1 n= 3–4, D7 n = 3–4, D11 n = 5–6, D40 n = 5
Figure 3 YZ1, YK26 3B: 4, 3D: 2 3B: manual n = 43, AG3000 n = 21, AG8000 n= 26; 3D: Manual/Aggrewell n = 10
Figure 4 YZ1, YK26 4H/J: 2 4H: Matrigel and POL n = 10; 4J: Matrigel and POL n = 22
Figure 5 YZ1, YK26 5F, G: manual:
5; rosette: 18;
FACS: 6
5F, G: Manual n = 15; Rosette n = 30; FACS n = 6
Figure 6 YZ1, YK26,
fAD 2a, b
6B/D: 2 6B: n = 11–26; 6D: n = 6, both time-points
Figure 7 YZ1, YK26 7C,D: 6; 7F: 5 7C,D: D40–50 n = 29–38, D100 n= 15–19; 7F: Neurons alone n= 20 for MAP2, TBR1, CUX1, GAD1,
n = 37 for SYP, n = 38 for VGLUT1; Astrocyte Co-culture n = 17 for GAD1, n = 18 for MAP2, TBR1,
CUX1, n = 27 for SYP, n = 25 for VGLUT1
*10/10 differentiations without dissociation failed. 3/5 differentiations with dissociation yielded MAP2+ cells.
doi:10.1371/journal.pone.0105807.t002
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cells using a BD FACSAria cell sorter. Cells were either harvested
after sorting for RNA analysis or plated on Matrigel for
immunostaining and confocal microscopy analysis.
Statistics
Data was analyzed using GraphPad PRISM 5/6 software.
Values are expressed as means 6S.D. or 6SEM, as indicated by
figure legend text. Statistical significance was tested by either an
unpaired Student’s t-test (two-tailed), by one-way ANOVA with a
Tukey’s post-test, or by two-way ANOVA with Holm-Sidak
multiple comparisons correction (as indicated by figure legend
text). Statistically significant differences were determined by P
values less than 0.05.
Table 3. Probe sequences for NanoString assay.
NanoString
genes Probe Sequence
AFP GGAGCGGCTGACATTATTATCGGACACTTATGTATCAGACATGAAATGACTCCAGTAAACCCTGGTGTTGGCCAGTGCTGCACTTCTTCATATGCCAACA
Cux1 ACAAACAGCCCTGGAAAAAACTCGAACAGAATTATTTGACCTGAAAACCAAATACGATGAAGAAACTACTGCAAAGGCCGACGAGATTGAAATGATCATG
EN1 GCAGCATTTTTGAAAAGGGAGAAAGACTCGGACAGGTGCTATCGAAAAATAAGATCCATTCTCTATTCCCAGTATAAGGGACGAAACTGCGAACTCCTTA
FoxG1 CTGACAAGTCTATCTCTAAGAGCCGCCAGATTTCCATGTGTGCAGTATTATAAGTTATCATGGAACTATATGGTGGACGCAGACCTTGAGAACAACCTAA
GFAP AAGCAGATGAAGCCACCCTGGCCCGTCTGGATCTGGAGAGGAAGATTGAGTCGCTGGAGGAGGAGATCCGGTTCTTGAGGAAGATCCACGAGGAGGAGGT
HES1 ATCTGAGCACAGAAAGTCATCAAAGCCTATTATGGAGAAAAGACGAAGAGCAAGAATAAATGAAAGTCTGAGCCAGCTGAAAACACTGATTTTGGATGCT
HES5 CAGCCTGTAGAGGACTTTCTTCAGGGCCCGTAGCTGCTGGGCGTACCCCTGGCAGGCGGGCTGTGCCGCGGGCACATTTGCCTTTTGTGAAGGCCGAACT
HNK1 GAGGGAGGCCTGAGCACACTGCTTTGGAAATTATTCTAAACACAAAAAAGGGAAAGAAAATGTTATTTCTCCCTAAGTCAGGAGCATGCAGAGCTAGCCC
HB9 CCTGGGCGCTTCCCTTTTAAGCAAGGGCGCCTCACCTGCTCTTCAAGAAACAGCGAGAGGGAGACCCAGGGGGCTGAAACTTGAACTCTGGTTCTTTTAA
HOXB6 CACCCATTCCTTTAAATCCGGAGGGGGAAAAAATCCCAAGGTCTGCAAAGGCGCGGCGCTCGGACTATAAAACACAACAAATCATAAACCCGGCGGAGCA
HOXB13 CCACCAGGGTTCCCAAAGAACCTGGCCCAGTCATAATCATTCATCCTGACAGTGGCAATAATCACGATAACCAGTACTAGCTGCCATGATCGTTAGCCTC
KCC2 ATGAGAGCGACATCTCAGCTTACACCTATGAGAAGACGTTGGTGATGGAGCAGCGTTCCCAGATCCTCAAACAGATGCATTTAACCAAGAATGAGCGGGA
MAP2 TACTCTGTATGCTGGGATTCCGAGGTTCCAACACACTGTTACAAATCTGTGGGGGGTTTCTTTCTTCTGATAATTCTAGAGCCTGTTACCATAGAAAGGC
MYOD1 TGTAATCTATTCCTGTAAATAAGAGTTGCTTTGCCAGAGCAGGAGCCCCTGGGGCTGTATTTATCTCTGAGGCATGGTGTGTGGTGCTACAGGGAATTTG
Nanog TGCAGGCAACTCACTTTATCCCAATTTCTTGATACTTTTCCTTCTGGAGGTCCTATTTCTCTAACATCTTCCAGAAAAGTCTTAAAGCTGCCTTAACCTT
Nestin CAGAGAATCACAAATCACTGAGGTCTTTAGAAGAACAGGACCAAGAGACATTGAGAACTCTTGAAAAAGAGACTCAACAGCGACGGAGGTCTCTAGGGGA
NMDAR TTCAAGAGAGTGCTGATGTCTTCCAAGTATGCGGATGGGGTGACTGGTCGCGTGGAGTTCAATGAGGATGGGGACCGGAAGTTCGCCAACTACAGCATCA
Oct4 AAGTTCTTCATTCACTAAGGAAGGAATTGGGAACACAAAGGGTGGGGGCAGGGGAGTTTGGGGCAACTGGTTGGAGGGAAGGTGAAGTTCAATGATGCTC
Pax6 GGGAATTAAAGGCCTTCAGTCATTGGCAGCTTAAGCCAAACATTCCCAAATCTATGAAGCAGGGCCCATTGTTGGTCAGTTGTTATTTGCAATGAAGCAC
PSD95 TGCCCTGAAGAATGCGGGTCAGACGGTCACGATCATCGCTCAGTATAAACCAGAAGAGTACAGCCGATTCGAGGCCAAGATCCACGACCTTCGGGAACAG
S100B AGAAGGCCATGGTGGCCCTCATCGACGTTTTCCACCAATATTCTGGAAGGGAGGGAGACAAGCACAAGCTGAAGAAATCCGAACTCAAGGAGCTCATCAA
Satb1 TTCCGAAATCTACCAGTGGGTACGCGATGAACTGAAACGAGCAGGAATCTCCCAGGCGGTATTTGCACGTGTGGCTTTTAACAGAACTCAGGGCTTGCTT
Sox1 AAAGCGTTTTCTTTGCTCGAGGGGACAAAAAAGTCAAAACGAGGCGAGAGGCGAAGCCCACTTTTGTATACCGGCCGGCGCGCTCACTTTCCTCCGCGTT
Sox2 AAAGCGTTTTCTTTGCTCGAGGGGACAAAAAAGTCAAAACGAGGCGAGAGGCGAAGCCCACTTTTGTATACCGGCCGGCGCGCTCACTTTCCTCCGCGTT
Synapsin GGATCTACTTCTGTTTTAGAACCTCCACATTCCTGAAGACCTCCGCCCCTGGTTTCCCCAGAGGGCGTTTTCCTTCCTGGAAGTGCCCAAATACCAGGCA
Tau ATTGGGTCCCTGGACAATATCACCCACGTCCCTGGCGGAGGAAATAAAAAGATTGAAACCCACAAGCTGACCTTCCGCGAGAACGCCAAAGCCAAGACAG
Tbr1 GCCGTCTGCAGCGAATAAGTGCAGGTCTCCGAGCGTGATTTTAACCTTTTTTGCACAGCAGTCTCTGCAATTAGCTCACCGACCTTCAACTTTGCTGTAA
Tbr2 TCTCTAGATTCCAATGATTCAGGAGTATACACCAGTGCTTGTAAGCGAAGGCGGCTGTCTCCTAGCAACTCCAGTAATGAAAATTCACCCTCCATAAAGT
TWIST1 CAACTCCCAGACACCTCGCGGGCTCTGCAGCACCGGCACCGTTTCCAGGAGGCCTGGCGGGGTGTGCGTCCAGCCGTTGGGCGCTTTCTTTTTGGACCTC
VGAT CAGGCTGGAACGTGACCAACGCCATCCAGGGCATGTTCGTGCTGGGCCTACCCTACGCCATCCTGCACGGCGGCTACCTGGGGTTGTTTCTCATCATCTT
VGLUT1 TCGGCTACTCGCACTCCAAGGGCGTGGCCATCTCCTTCCTGGTCCTAGCCGTGGGCTTCAGCGGCTTCGCCATCTCTGGGTTCAACGTGAACCACCTGGA
Vimentin GAGGAGATGCTTCAGAGAGAGGAAGCCGAAAACACCCTGCAATCTTTCAGACAGGATGTTGACAATGCGTCTCTGGCACGTCTTGACCTTGAACGCAAAG
Housekeeping genes:
B2M CGGGCATTCCTGAAGCTGACAGCATTCGGGCCGAGATGTCTCGCTCCGTGGCCTTAGCTGTGCTCGCGCTACTCTCTCTTTCTGGCCTGGAGGCTATCCA
GAPDH TCCTCCTGTTCGACAGTCAGCCGCATCTTCTTTTGCGTCGCCAGCCGAGCCACATCGCTCAGACACCATGGGGAAGGTGAAGGTCGGAGTCAACGGATTT
GUSB CGGTCGTGATGTGGTCTGTGGCCAACGAGCCTGCGTCCCACCTAGAATCTGCTGGCTACTACTTGAAGATGGTGATCGCTCACACCAAATCCTTGGACCC
HPRT1 TGTGATGAAGGAGATGGGAGGCCATCACATTGTAGCCCTCTGTGTGCTCAAGGGGGGCTATAAATTCTTTGCTGACCTGCTGGATTACATCAAAGCACTG
LDHA AACTTCCTGGCTCCTTCACTGAACATGCCTAGTCCAACATTTTTTCCCAGTGAGTCACATCCTGGGATCCAGTGTATAAATCCAATATCATGTCTTGTGC
POLR2A TTCCAAGAAGCCAAAGACTCCTTCGCTTACTGTCTTCCTGTTGGGCCAGTCCGCTCGAGATGCTGAGAGAGCCAAGGATATTCTGTGCCGTCTGGAGCAT
RPL13a AGTCCAGGTGCCACAGGCAGCCCTGGGACATAGGAAGCTGGGAGCAAGGAAAGGGTCTTAGTCACTGCCTCCCGAAGTTGCTTGAAAGCACTCGGAGAAT
RPL27 GGGCCGGGTGGTTGCTGCCGAAATGGGCAAGTTCATGAAACCTGGGAAGGTGGTGCTTGTCCTGGCTGGACGCTACTCCGGACGCAAAGCTGTCATCGTG
doi:10.1371/journal.pone.0105807.t003
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Supporting Information
Figure S1 Expression of forebrain cortical vs. mid- or
hindbrain transcription factors. Day 17 (NPC) or day 40
(neuron) RNA (same samples as used in Figures 5 or 6D,
respectively). NanoString counts show robust cortical transcription
factor expression (FoxG1, Sox1, Sox2, Tbr1, Tbr2, HES1, HES5)
and negligible expression of non-cortical transcription factors (EN-
1, HB9, HOXB6, HOXB13).
(TIF)
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